Celularity Incorporated
Clinical trials sponsored by Celularity Incorporated, explained in plain language.
-
Cancer cell therapy trial for brain tumor withdrawn before starting
Disease control TerminatedThis study planned to test a new treatment combining CYNK-001 (natural killer cells from donated cord blood) with interleukin-2 in adults whose glioblastoma had returned and could be surgically removed. The goal was to see if this combination was safe and could extend the time be…
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
Placenta cells aim to save limbs in diabetic foot ulcer trial
Disease control TerminatedThis study tested whether injections of cells from donated placentas could improve blood flow and help heal foot ulcers in people with diabetes and blocked leg arteries. The trial planned to enroll about 24 adults with hard-to-heal foot sores. However, the study was withdrawn bef…
Phase: PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC